Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.

Autor: Kahraman S; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey. sedakayacan.kahraman@gmail.com., Karakaya S; Department of Medical Oncology, Ankara Ataturk Sanatoryum Training and Research Hospital, Ankara, Turkey., Kaplan MA; Department of Medical Oncology, Dicle University Medical Faculty Hospital, Diyarbakir, Turkey., Goksu SS; Department of Medical Oncology, Akdeniz University Hospital, Antalya, Turkey., Ozturk A; Department of Medical Oncology, Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey., Isleyen ZS; Department of Medical Oncology, Faculty of Medicine Hospital, Bezmialem Vakif University, Istanbul, Turkey., Hamdard J; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey., Yildirim S; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey., Dogan T; Department of Medical Oncology, Pamukkale University Medical Faculty Hospital, Denizli, Turkey., Isik S; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey., Celebi A; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey., Gulbagci BB; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey., Paksoy N; Department of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey., Dogan M; Department of Medical Oncology, Ankara Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Turk HM; Department of Medical Oncology, Faculty of Medicine Hospital, Bezmialem Vakif University, Istanbul, Turkey., Bilici A; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey., Tatli AM; Department of Medical Oncology, Akdeniz University Hospital, Antalya, Turkey., Akbas S; Department of Medical Oncology, Koç University Medical Faculty Hospital, Istanbul, Turkey., Turan N; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey., Hacibekiroglu I; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey., Dogu GG; Department of Medical Oncology, Pamukkale University Medical Faculty Hospital, Denizli, Turkey., Aydiner A; Department of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey., Sumbul AT; Department of Medical Oncology, Baskent University Adana Dr. Turgut Noyan Application and Research Center, Adana, Turkey., Akyurek S; Department of Radiation Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Yalciner M; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Demirkazik A; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Gursoy P; Department of Medical Oncology, Ege University Medical Faculty Hospital, Izmir, Turkey., Aykan MB; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey., Sahin E; Department of Medical Oncology, Kocaeli University Medical Faculty Hospital, Kocaeli, Turkey., Karadag İ; Department of Medical Oncology, Hittite University Corum Training and Research Hospital, Corum, Turkey., Kostek O; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey., Er MM; Department Of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey., Artaç M; Department Of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey., Duzkopru Y; Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkey., Aydin D; Department of Medical Oncology, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey., Isik D; Department of Medical Oncology, Kocaeli Medical Park Hospital, Kocaeli, Turkey., Karakas Y; Department of Medical Oncology, Acıbadem Bodrum Hospital, Mugla, Turkey., Kilickap S; Department of Medical Oncology, Liv Hospital, Istinye University, Ankara, Turkey., Erol C; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey., Demir B; Department of Medical Oncology, Aydin Ataturk State Hospital, Aydin, Turkey., Civelek B; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Turkey., Ergun Y; Department of Medical Oncology, Batman Training and Research Hospital, Batman, Turkey., Akinci MB; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey., Dogan I; Department of Medical Oncology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey., Karadurmus N; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey., Yumuk PF; Department of Medical Oncology, Koç University Medical Faculty Hospital, Istanbul, Turkey., Sendur MAN; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.

Publikováno v: Scientific reports [Sci Rep] 2024 Mar 09; Vol. 14 (1), pp. 5820. Date of Electronic Publication: 2024 Mar 09.

The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey.

Autor: Akyildiz A; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Guven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Ozluk AA; Department of Medical Oncology, Ege University Faculty of Medicine, Izmir, Turkey., Ismayilov R; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey., Mutlu E; Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey., Unal OU; Department of Medical Oncology, Bozyaka Education and Research Hospital, Izmir, Turkey., Yildiz I; Department of Medical Oncology, Acibadem University Hospital, Istanbul, Turkey., Iriagac Y; Department of Medical Oncology, Namik Kemal University, Tekirdag, Turkey., Turhal S; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey., Akbas S; Department of Medical Oncology, Koc University Hospital, Istanbul, Turkey., Bayram E; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Telli TA; Department of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey., Turkoz FP; Department of Medical Oncology, Istinye University, Medical Park Goztepe Hospital, Istanbul, Turkey., Ozcelik M; Department of Oncology, Kartal Lutfi Kirdar Teaching and Research Hospital, Istanbul, Turkey., Erciyestepe M; Department of Medical Oncology, Prof Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey., Selvi O; Department of Medical Oncology, Prof Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey., Gulbagci B; Department of Medical Oncology, Sakarya University Faculty of Medicine, Sakarya, Turkey., Erturk I; Department of Medical Oncology, Gulhane School of Medicine, Ankara, Turkey., Isleyen ZS; Department of Medical Oncology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey., Kahraman S; Department of Medical Oncology, Ankara City Hospital, Yildirim Beyazit University, Ankara, Turkey., Akdag MO; Department of Medical Oncology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey., Hamitoglu B; Department of Medical Oncology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey., Unek IT; Department of Medical Oncology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey., Unal C; Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey., Hacibekiroglu İ; Department of Medical Oncology, Prof Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey., Arslan C; Department of Medical Oncology, Izmir University of Economics Faculty of Medicine, Izmir, Turkey., Azizy A; Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey., Helvaci K; Department of Medical Oncology, Memorial Ankara Hospital, University of Uskudar, Ankara, Turkey., Demirci U; Department of Medical Oncology, Memorial Ankara Hospital, University of Uskudar, Ankara, Turkey., Dizdar O; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Basaran M; Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey., Goker E; Department of Medical Oncology, Ege University Faculty of Medicine, Izmir, Turkey., Sendur MA; Department of Medical Oncology, Ankara City Hospital, Yildirim Beyazit University, Ankara, Turkey., Yalcin S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.

Publikováno v: Medicine [Medicine (Baltimore)] 2023 Nov 10; Vol. 102 (45), pp. e35950.

Anxiety levels of breast cancer patients in Turkey during the COVID-19 pandemic.

Autor: Yasin AI; Department of Medical Oncology, Bezmialem Vakif University, Istanbul, 34093, Turkey., Topcu A; Department of Medical Oncology, Bezmialem Vakif University, Istanbul, 34093, Turkey., Shbair AT; Department of Medical Oncology, Bezmialem Vakif University, Istanbul, 34093, Turkey., Isleyen ZS; Department of Medical Oncology, Bezmialem Vakif University, Istanbul, 34093, Turkey., Ozturk A; Department of Psychiatry, Bezmialem Vakif University, Istanbul, 34093, Turkey., Besiroglu M; Department of Medical Oncology, Bezmialem Vakif University, Istanbul, 34093, Turkey., Türk HM; Department of Medical Oncology, Bezmialem Vakif University, Istanbul, 34093, Turkey.

Publikováno v: Future oncology (London, England) [Future Oncol] 2021 Sep; Vol. 17 (25), pp. 3373-3381. Date of Electronic Publication: 2021 Jul 22.

Evidence of the Efficacy and the Effectiveness of First Generation COVID-19 Vaccines in Clinical Trials and Real-world Studies.

Autor: Jingxin Li, Zhuopei Li, Yawen Zhu, Li Zhou, Fengcai Zhu

Publikováno v: Zoonoses (2737-7466); 2022, Vol. 2 Issue 1, p1-16, 16p